English
Advances in multiple Sclerosis and Experimental Demyelinating Diseases
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.
-
Altmetric BadgeChapter 2 Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.
-
Altmetric BadgeChapter 3 Multiple sclerosis genetics.
-
Altmetric BadgeChapter 4 Imaging of remyelination and neuronal health.
-
Altmetric BadgeChapter 5 Immunological aspects of axon injury in multiple sclerosis.
-
Altmetric BadgeChapter 6 The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.
-
Altmetric BadgeChapter 7 Genetic Analysis of CNS Remyelination
-
Altmetric BadgeChapter 8 Remyelination in Experimental Models of Toxin-Induced Demyelination
-
Altmetric BadgeChapter 9 Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
-
Altmetric BadgeChapter 10 Neuroimaging of demyelination and remyelination models.
-
Altmetric BadgeChapter 11 Hormonal influences in multiple sclerosis.
-
Altmetric BadgeChapter 12 Statins and demyelination.
-
Altmetric BadgeChapter 13 Role of uric acid in multiple sclerosis.
-
Altmetric BadgeChapter 14 Neuromyelitis Optica: Clinical Syndrome and the NMO-IgG Autoantibody Marker